Venstra Medical is pleased to share preclinical results of our pVAD system development at #TCT2025 presented by Dr. Suku Thambar, Chief Medical Officer, at "Innovation Session 10: Advances in Percutaneous Pump Updates" beginning at noon on Monday, October 27th at Exhibition Level | Hall E | Innovation Theater.

There's no better validation of our development efforts at VenstraMedical than to get featured in Forbes Magazine! We are eager to get our technology to those who could benefit from our FULL hemodynamic support while being delivered in a small 9F platform.

https://tinyurl.com/5ca5fh7p

Venstramedical is proud to be featured in the American Society for Artificial Organs (ASAIO) Journal highlighting the pre-clinical testing of our novel pVAD platform.
https://tinyurl.com/yxtbcd99